JPH0427203B2 - - Google Patents
Info
- Publication number
- JPH0427203B2 JPH0427203B2 JP61116137A JP11613786A JPH0427203B2 JP H0427203 B2 JPH0427203 B2 JP H0427203B2 JP 61116137 A JP61116137 A JP 61116137A JP 11613786 A JP11613786 A JP 11613786A JP H0427203 B2 JPH0427203 B2 JP H0427203B2
- Authority
- JP
- Japan
- Prior art keywords
- hydroxyapatite
- appropriate amount
- spherical
- pigments
- cosmetics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 25
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 25
- 239000000049 pigment Substances 0.000 claims description 23
- 239000002537 cosmetic Substances 0.000 claims description 13
- 229940057995 liquid paraffin Drugs 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 7
- 239000003755 preservative agent Substances 0.000 description 7
- 239000004166 Lanolin Substances 0.000 description 5
- 235000019388 lanolin Nutrition 0.000 description 5
- 229940039717 lanolin Drugs 0.000 description 5
- 239000004606 Fillers/Extenders Substances 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 238000004040 coloring Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- 229910052623 talc Inorganic materials 0.000 description 4
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000004204 candelilla wax Substances 0.000 description 3
- 235000013868 candelilla wax Nutrition 0.000 description 3
- 229940073532 candelilla wax Drugs 0.000 description 3
- 239000004203 carnauba wax Substances 0.000 description 3
- 235000013869 carnauba wax Nutrition 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 229960004418 trolamine Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- BHIZVZJETFVJMJ-UHFFFAOYSA-N 2-hydroxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)O BHIZVZJETFVJMJ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229910014497 Ca10(PO4)6(OH)2 Inorganic materials 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- PVNIQBQSYATKKL-UHFFFAOYSA-N Glycerol trihexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- CUSKZEYVILQFHM-UHFFFAOYSA-N [Bi].O=O Chemical compound [Bi].O=O CUSKZEYVILQFHM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- POJOORKDYOPQLS-UHFFFAOYSA-L barium(2+) 5-chloro-2-[(2-hydroxynaphthalen-1-yl)diazenyl]-4-methylbenzenesulfonate Chemical compound [Ba+2].C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O.C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O POJOORKDYOPQLS-UHFFFAOYSA-L 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- LQJVOKWHGUAUHK-UHFFFAOYSA-L disodium 5-amino-4-hydroxy-3-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].OC1=C2C(N)=CC(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=C1N=NC1=CC=CC=C1 LQJVOKWHGUAUHK-UHFFFAOYSA-L 0.000 description 1
- FHRUGNCCGSEPPE-UHFFFAOYSA-L disodium;2-(4,5-dibromo-3,6-dioxido-9h-xanthen-9-yl)benzoate;hydron Chemical compound [H+].[Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1C2=CC=C([O-])C(Br)=C2OC2=C(Br)C([O-])=CC=C21 FHRUGNCCGSEPPE-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- -1 lipstick Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- ZHALDANPYXAMJF-UHFFFAOYSA-N octadecanoate;tris(2-hydroxyethyl)azanium Chemical compound OCC[NH+](CCO)CCO.CCCCCCCCCCCCCCCCCC([O-])=O ZHALDANPYXAMJF-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000011049 pearl Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940029614 triethanolamine stearate Drugs 0.000 description 1
- 239000012463 white pigment Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Pigments, Carbon Blacks, Or Wood Stains (AREA)
- Cosmetics (AREA)
Description
産業上の利用
本発明は、化粧品用の顔料としての球状のハイ
ドロキシアパタイトに関するものである。
従来の技術
従来より白粉、口紅、その他の化粧品には、
種々の顔料、例えば、タルク、炭酸カルシウム、
カオリンなどの体質顔料、酸化亜鉛、酸化チタン
などの白色顔料、酸化鉄、群青、クロム緑などの
着色顔料、魚鱗箔、マイカ、雲母チタン、オキシ
酸化ビスマスなどのパール顔料、及びステアリン
酸マグネシウム、パルミチン酸亜鉛などの金属石
ケン、その他が使用されている。これらの中で白
色顔料は最も多く使用されており、白色に着色す
る外、他の着色顔料と混合して色合を変え、隠蔽
力を大きくし、被覆力を調整している。体質顔料
は着色顔料をうすめて、適当な濃さにして着色を
調整し又感触を調整している。パール顔料は光沢
を与え、金属石ケンは皮膚への付着力の向上、油
中への顔料分散をよくするために使用されてい
る。ハイドロキシアパタイトCa10（PO4）6（OH）2
は歯骨など人体に存在する無機質で、人体に悪影
響を及ぼさないので、歯磨研磨材、骨補修材とし
て使用されている。然しながら顔料として化粧品
に使用することは試みられていない。
発明が解決しようとする問題点
最近化粧品による皮膚障害が問題となつている
ので本発明は人体に存在し悪影響を及ぼさないハ
イドロキシアパタイトを従来化粧品に使用されて
いる顔料の代りに使用することにより、人体によ
り安全な化粧品を提供することにある。
問題を解決するための手段
ハイドロキシアパタイトをゼツトミル、ミクロ
ンミル、コロイドミルなどの超微粉砕機を用いて
微粉とし篩分けして一定範囲の大きさの粉子を採
取するか、又はポリエステル、ポリエチレン、ナ
イロン、ポリメチルメタアクリレート、その他球
型にそろえられたポリマー球に、ハイドロキシア
パタイト微粉末を、シリコンアクリルエマルジヨ
ン、ウレタンアクリルエマルジヨンなどの結合剤
の存在下約20゜から80℃の温度大気圧下に混合し、
次いで乾燥させてポリマ球表面にハイドロキシア
パタイト微粉末を付着させた粒子（以下球状ハイ
ドロキシアパタイトと記す）を篩分けして一定範
囲の大きさの粉子を採取して従来の白色顔料、体
質顔料の代りに化粧品に使用する。使用するハイ
ドロキシアパタイト、球状ハイドロキシアパタイ
トの粒子の大きさは小さければ小さい程、化粧品
の均質性を向上させるのは当然であるが、微粒子
にすぎると皮膚を通して体内にとり込まれる可能
性があるので、使用するそれらの粒子の大きさ
は、反射率、屈折率なども考慮に入れ3μ〜10μ程
度であることが望ましい。
作 用
このようにして得られた球状ハイドロキシアパ
タイトは従来の顔料の場合と同様に処理すること
により各種の化粧品を製造することができる。
以下に本発明を具体的に実施例で説明する。数
字はいずれも重量％を示している。
例 １
油性軟膏型フアンデーシヨン
球状ハイドロキシアパタイト 30
粉末ハイドロキルアパタイト 10
パルミテン酸イソプロピル 15
ラノリンアルコール ５
酢酸ラノリン ８
マイクロクリスタリンワツクス ７
流動パラフイン 25
キヤンデリラロウ 0.5
防腐剤、酸化防止剤 適 量
香 料 〃
例 ２
油性ステイツク型フアンデーシヨン
球状ハイドロキルアパタイト 30
粉末ハイドロキルアパタイト 15
流動パラフイン 18
ミリスチン酸イソプロピル 15
液状ラノリン 4.5
マイクロクリスタリンワツクス 4.5
セレシン 10
カルナウバロウ ２
セスキオレイン酸ソルビタン １
酸化防止剤・防腐剤 適 量
香 料 適 量
例 ３
乳液状フアンデーシヨン
球状ハイドロキシアパタイト 12
ステアリン酸 2.4
モノステアリン酸プロピレングリコール ２
セトステアリルアルコール 0.2
液状ラノリン ２
流動パラフイン ３
ミリスチン酸イソプロピル 8.5
パラオキシ安息香酸プロピル 適 量
カルボキシメチルロースナトリウム 0.2
ベントナイト 0.5
プロピレングリコール ４
トリエタノールアミン 1.1
パラオキシ安息香酸メチル 適 量
精製水 64.1
香 料 適 量
例 ４
クリーム状フアウンデーシヨン
球状ハイドロキルアパタイト16
ステアリン酸 ５
親油性モノステアリン酸グリセリン 2.5
セトステアリルアルコール １
モノステアリルアルコール １
モノラウリン酸プロピレングリコール ３
流動パラフイン ７
ミリスチン酸イソプロピル ８
パラオキシ安息香酸ブチル 適 量
トリエタノールアミン 1.2
ソルビツト ３
パラオキシ安息香酸メチル 適 量
精製水 53.3
香 料 適 量
例 ５
ケーキ型フアンデーシヨン
球状ハイドロキシアパタイト 40
粉末ハイドロキシアパタイト 40
流動パラフイン 12
セスキオレイン酸ソルビタン ４
グリセリン ４
防腐剤 適 量
香 料 適 量
例 ６
ステイツク型口紅
球状ハイドロキルアパタイト ２
赤色202号 0.5
赤色204号 2.5
赤色227号A1レーキ 2.5
橙色201号 0.2
ヒマシ油 45.3
ヘキサデシルアルコール 25
ミツロウ ９
キヤンデリラロウ ７
カルナウバロウ ２
酸化防止剤、防腐剤 適 量
香 料 適 量
例 ７
固形ほほ紅
球状ハイドロキシアパタイト 15
粉末ハイドロキシアパタイト 15
タルク 40
カオリン 20
流動パラフイン ５
コメデンプン ５
香 料 適 量
例 ８
ケーキ型アイライナー
球状ハイドロキシアパタイト 30
粉末ハイドロキシアパタイト 15
タルク 35
流動パラフイン 15
ソルビタンセスキオレエート ５
防腐剤 適 量
香 料 〃
例 ９
固形マスカラ
球状ハイドロキルアパタイト 18
ステアリン酸トリエタノールアミン 26
パラフイン 26
ミツロウ 17
ラノリン 10
カルナウバロウ ３
防腐剤 適 量
例 10
ステイツク型アイシヤドー
球状ハイドロキルアパタイト ８
着色顔料 ８
セレシン 25
硬化綿実油 16
ヒマシ油 33
流動パラフイン ６
キヤンデリラロウ ４
防腐剤酸化防止剤 適 量
例 11
粉おしろい
球状ハイドロキルアパタイト 45
粉末ハイドロキルアパタイト 15
タルク 40
着色顔料 適 量
香 料 適 量
例 12
例４の組成を有するクリーム状フアンデーシヨ
ン及び例４の球状ハイドロキシアパタイトの代わ
りに夫々粉末ハイドロキシアパタイト（例4′）、
酸化亜鉛（比較例１）及び酸化チタン（比較例
２）を使用したフアンデーシヨンを作成し、各試
料について使用比較試験を女性検査員20名で行い
下記の結果を得た。
Industrial Application The present invention relates to spherical hydroxyapatite as a pigment for cosmetics. Conventional technology Traditionally, white powder, lipstick, and other cosmetics use
Various pigments, such as talc, calcium carbonate,
Extender pigments such as kaolin, white pigments such as zinc oxide and titanium oxide, colored pigments such as iron oxide, ultramarine, and chromium green, pearl pigments such as fish scale foil, mica, titanium mica, and bismuth oxyoxide, and magnesium stearate and palmitin. Metal soaps such as acid zinc and others are used. Among these, white pigments are most commonly used, and in addition to being colored white, they are mixed with other colored pigments to change the hue, increase hiding power, and adjust covering power. Extender pigments are used to dilute coloring pigments to an appropriate density to adjust coloring and texture. Pearl pigments give luster, and metal soaps are used to improve adhesion to the skin and improve pigment dispersion in oil. Hydroxyapatite Ca 10 (PO 4 ) 6 (OH) 2
is an inorganic substance that exists in the human body, such as dental bones, and has no adverse effect on the human body, so it is used as a tooth polishing material and a bone repair material. However, no attempt has been made to use it as a pigment in cosmetics. Problems to be Solved by the Invention Recently, skin damage caused by cosmetics has become a problem, so the present invention uses hydroxyapatite, which exists in the human body and does not have any adverse effects, in place of pigments conventionally used in cosmetics. Our goal is to provide cosmetics that are safer for the human body. Means to solve the problem Hydroxyapatite is made into a fine powder using an ultrafine grinder such as a Zetsu mill, a micron mill, or a colloid mill. Hydroxyapatite fine powder is placed in nylon, polymethyl methacrylate, or other polymer spheres arranged in a spherical shape at a temperature of approximately 20° to 80°C and atmospheric pressure in the presence of a binder such as silicone acrylic emulsion or urethane acrylic emulsion. mix below,
Next, the particles (hereinafter referred to as spherical hydroxyapatite) with fine hydroxyapatite powder adhered to the surface of the polymer spheres are dried and sieved to collect powders of a certain size range, which are used to prepare conventional white pigments and extender pigments. Use in cosmetics instead. Naturally, the smaller the particle size of hydroxyapatite and spherical hydroxyapatite used, the better the homogeneity of cosmetics, but if the particles are too fine, they may be taken into the body through the skin, so The size of these particles is desirably about 3 μ to 10 μ, taking into account reflectance, refractive index, etc. Function The spherical hydroxyapatite thus obtained can be treated in the same manner as conventional pigments to produce various cosmetics. The present invention will be specifically explained below with reference to Examples. All numbers indicate weight %. Example 1 Oil-based ointment type foundation Spherical hydroxyapatite 30 Powdered hydroxylapatite 10 Isopropyl palmitate 15 Lanolin alcohol 5 Lanolin acetate 8 Microcrystalline wax 7 Liquid paraffin 25 Candelilla wax 0.5 Preservatives, antioxidants Appropriate amount fragrance Example 2 Oil-based standing foundation Spherical hydrokylapatite 30 Powdered hydrokylapatite 15 Liquid paraffin 18 Isopropyl myristate 15 Liquid lanolin 4.5 Microcrystalline wax 4.5 Ceresin 10 Carnauba wax 2 Sorbitan sesquioleate 1 Antioxidant/preservative Appropriate amount fragrance Example of appropriate amount 3 Milky foundation spherical hydroxyapatite 12 Stearic acid 2.4 Propylene glycol monostearate 2 Cetostearyl alcohol 0.2 Liquid lanolin 2 Liquid paraffin 3 Isopropyl myristate 8.5 Propyl paraoxybenzoate Appropriate amount Sodium carboxymethylulose 0.2 Bentonite 0.5 Propylene Glycol 4 Triethanolamine 1.1 Methyl paraoxybenzoate Appropriate amount Purified water 64.1 Fragrance Appropriate amount example 4 Creamy foundation spherical hydrokylapatite 16 Stearic acid 5 Lipophilic glyceryl monostearate 2.5 Cetostearyl alcohol 1 Monostearyl alcohol 1 Propylene glycol monolaurate 3 Liquid paraffin 7 Isopropyl myristate 8 Butyl paraoxybenzoate Appropriate amount Triethanolamine 1.2 Sorbit 3 Methyl paraoxybenzoate Appropriate amount Purified water 53.3 Fragrance Appropriate amount example 5 Cake type foundation Spherical hydroxyapatite 40 Powdered hydroxy Apatite 40 Liquid paraffin 12 Sorbitan sesquioleate 4 Glycerin 4 Preservatives Appropriate amount Fragrance Appropriate amount Example 6 Stick-type lipstick spherical hydrokylapatite 2 Red No. 202 0.5 Red No. 204 2.5 Red No. 227 A1 Lake 2.5 Orange No. 201 0.2 Castor oil 45.3 Hexadecyl alcohol 25 Beeswax 9 Candelilla wax 7 Carnauba wax 2 Antioxidants, preservatives Appropriate amount Flavoring Appropriate amount example 7 Solid pink spherical hydroxyapatite 15 Powdered hydroxyapatite 15 Talc 40 Kaolin 20 Liquid paraffin 5 Rice starch 5 Flavoring Appropriate amount Example 8 Cake-shaped eyeliner spherical hydroxyapatite 30 Powdered hydroxyapatite 15 Talc 35 Liquid paraffin 15 Sorbitan sesquioleate 5 Preservative Appropriate amount of fragrance Example 9 Solid mascara spherical hydroxyapatite 18 Triethanolamine stearate 26 Paraffin 26 Beeswax 17 Lanolin 10 Carnauba wax 3 Preservative Example of appropriate amount 10 Stick-type eye shadow spherical hydrokylapatite 8 Coloring pigment 8 Ceresin 25 Hardened cottonseed oil 16 Castor oil 33 Liquid paraffin 6 Candelilla wax 4 Preservative antioxidant Example of appropriate amount 11 Powdered spherical hydrokylapatite 45 Powdered hydroxyapatite 15 Talc 40 Coloring pigment Appropriate amount Fragrance Appropriate amount Example 12 A cream foundation having the composition of Example 4, and powdered hydroxyapatite (Example 4') in place of the spherical hydroxyapatite of Example 4, respectively.
Foundations were prepared using zinc oxide (Comparative Example 1) and titanium oxide (Comparative Example 2), and 20 female inspectors conducted a comparative test on each sample, and obtained the following results.
【表】
発明の効果
このようにして得られた球状のハイドロキシア
パタイトは、安全であることに加えて、球状ハイ
ドロキシアパタイト自体の螢光色を帯びた白色と
いう性質により、顔料として化粧品に添加される
とき、得られる化粧品の色調をすき通るようなパ
ール状白色とし、人体との親和性が良いため皮膚
につけたときの感触を良好に高め、なじみがよ
く、皮膚への密着度があるのでのりの良い化粧と
なり、球状のハイドロキシアパタイトのみで、化
粧品中の体質顔料、白色顔料、パール顔料、金属
石ケンの機能を兼ねることができる。このため製
品の製作が容易であり、人体に対する副作用も削
減される。[Table] Effects of the invention In addition to being safe, the spherical hydroxyapatite thus obtained can be added to cosmetics as a pigment due to its fluorescent white property. When applied, the color of the cosmetics obtained is a piercing pearly white, and because it has good affinity with the human body, it feels good when applied to the skin. It makes good makeup, and the spherical hydroxyapatite alone can function as an extender pigment, white pigment, pearl pigment, and metal soap in cosmetics. Therefore, the product is easy to manufacture and side effects on the human body are reduced.
Claims (1)
品用の顔料。1 A cosmetic pigment made of spherical hydroxyapatite.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11613786A JPS62273907A (en) | 1986-05-22 | 1986-05-22 | Cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11613786A JPS62273907A (en) | 1986-05-22 | 1986-05-22 | Cosmetic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62273907A JPS62273907A (en) | 1987-11-28 |
| JPH0427203B2 true JPH0427203B2 (en) | 1992-05-11 |
Family
ID=14679646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11613786A Granted JPS62273907A (en) | 1986-05-22 | 1986-05-22 | Cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS62273907A (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0692288B2 (en) * | 1986-07-22 | 1994-11-16 | 株式会社資生堂 | External skin preparation |
| JPS6327411A (en) * | 1986-07-22 | 1988-02-05 | Shiseido Co Ltd | Dust preparation for skin external use |
| US6096324A (en) * | 1995-06-13 | 2000-08-01 | Laboratory Skin Care | Methods of delivering materials into the skin, and compositions used therein |
| US6579516B1 (en) | 1995-06-13 | 2003-06-17 | Zahra Mansouri | Methods of delivering materials into the skin, and compositions used therein |
| US6592882B2 (en) * | 1999-05-26 | 2003-07-15 | Color Access, Inc. | Cosmetic compositions containing fluorescent minerals |
| JP2008184399A (en) * | 2007-01-29 | 2008-08-14 | Shiseido Co Ltd | Powdery cosmetic |
| WO2016117640A1 (en) * | 2015-01-21 | 2016-07-28 | 株式会社 資生堂 | Makeup cosmetic |
| JP6034986B2 (en) * | 2015-01-21 | 2016-11-30 | 株式会社 資生堂 | Makeup cosmetics |
| JP2021008416A (en) * | 2019-06-28 | 2021-01-28 | サンスター スイス エスエー | Composition for oral cavity |
| CN113226984A (en) | 2018-12-27 | 2021-08-06 | 盛势达（瑞士）有限公司 | Oral composition |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61129108A (en) * | 1984-11-26 | 1986-06-17 | Shiseido Co Ltd | Makeup cosmetic |
| JPS6256415A (en) * | 1985-09-04 | 1987-03-12 | Shiseido Co Ltd | Cosmetic |
-
1986
- 1986-05-22 JP JP11613786A patent/JPS62273907A/en active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61129108A (en) * | 1984-11-26 | 1986-06-17 | Shiseido Co Ltd | Makeup cosmetic |
| JPS6256415A (en) * | 1985-09-04 | 1987-03-12 | Shiseido Co Ltd | Cosmetic |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62273907A (en) | 1987-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5122418A (en) | Composite powder and production process | |
| JP2636713B2 (en) | Improved anti-depression cosmetic composition | |
| JP2579735B2 (en) | Cosmetic composition for makeup containing a transparent pigment comprising titanium oxide and silicon oxide | |
| JP2524476B2 (en) | Cosmetic composition for makeup | |
| US5063050A (en) | Tableted powder cosmetics | |
| KR20070034983A (en) | Cosmetic composition containing pearlescent pigments of large synthetic mica | |
| KR102161465B1 (en) | cosmetic composition with increased skin contact and make-up persistence and manufacturing method of the same | |
| JP2004510718A (en) | Use of a cosmetic composition having a hydrophilic continuous phase containing a multilayer angular discoloration pigment as a make-up | |
| JP2004512348A (en) | Cosmetic composition containing a photochromic colorant and its use for makeup and / or care of skin and / or skin appendages | |
| US20050238979A1 (en) | Compositions for application to the skin, to the lips, to the nails, and/or to hair | |
| JPH10158115A (en) | Cosmetic | |
| JP5368043B2 (en) | Powdered solid cosmetic | |
| JPH0427203B2 (en) | ||
| JP2007126482A (en) | Cosmetic | |
| ES2272653T3 (en) | COMPOSITION OF CARE OR MAKEUP OF KERATINIC MATERIALS INCLUDING A NON-VOLATILE HYDROCARBON OIL, A PARTICULATED PHASE AND A SPECIFIC DISPERSANT AGENT. | |
| JP2572665B2 (en) | Coated pigment and cosmetic containing the same | |
| JPH08268839A (en) | Zinc oxide-coated extender pigment and cosmetics containing it | |
| JPH1112493A (en) | Composite powder and composition containing the same | |
| JP2004123681A (en) | Makeup cosmetic | |
| JP2004123682A (en) | Color pigment and makeup cosmetic | |
| JP4070356B2 (en) | Cosmetics | |
| JPS61129107A (en) | Makeup cosmetic | |
| JP3688859B2 (en) | Skin cosmetics | |
| JPS6256415A (en) | Cosmetic | |
| JPH045215A (en) | Cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |